Hemodynamics to Guide TAVR and MTEER
Presenter
Anita W. Asgar, M.D., FSCAI, Institut de Cardiologie de Montreal, Outremont, QC, Canada
Anita W. Asgar, M.D., FSCAI, Institut de Cardiologie de Montreal, Outremont, QC, Canada
Learning Objectives:
- Discuss hemodynamic assessment of AR and elevated gradients immediately after TAVR and when to treat
- Describe assessment of concomittant AS and LVOTO and when to consider septal reduction therapies
- Discuss how to integrate echo parameters and LA pressure and invasive MV gradients in determining optimization of MTEER
Keywords: Hemodynamic Support, Structural Heart Disease (SHD) and TEER/TMVR/Mitral Valve